tradingkey.logo
tradingkey.logo
Search

Forte Biosciences Inc

FBRX
Add to Watchlist
76.600USD
-0.380-0.49%
Close 07-31 16:00ETQuotes delayed by 15 min
1.57BMarket Cap
LossP/E TTM

FBRX Financials

See Forte Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Forte Biosciences Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-1.24/-1.20
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-4.71
61.29%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
9.64%-1.24
-18.84%-1.39
78.12%-0.99
85.87%-0.96
65.88%-1.37
74.89%-1.17
30.90%-4.54
35.84%-6.78
49.91%-4.03
19.76%-4.65
---6.57
---10.57
---8.04
---5.79
---13.92
----
----
----
----
----
Net Profit
-41.39%-22.14M
-246.44%-24.79M
-110.70%-17.68M
10.09%-11.25M
-111.00%-15.66M
-21.85%-7.16M
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.90M
-163.07%-6.75M
-45.97%-4.88M
56.13%-3.40M
47.78%-3.04M
46.57%-2.57M
26.99%-3.34M
-51.98%-7.75M
83.28%-5.81M
Operating profit
-39.17%-22.44M
-234.25%-24.57M
-113.04%-18.38M
9.67%-11.58M
-106.61%-16.12M
-15.20%-7.35M
15.53%-8.63M
-41.89%-12.82M
-13.84%-7.80M
-29.20%-6.38M
-198.45%-10.22M
-199.14%-9.03M
-172.67%-6.86M
-49.71%-4.94M
55.54%-3.42M
47.45%-3.02M
46.97%-2.51M
26.57%-3.30M
-53.73%-7.70M
-113.09%-5.75M
Net Profit
-41.39%-22.14M
-246.44%-24.79M
-110.70%-17.68M
10.09%-11.25M
-111.00%-15.66M
-21.85%-7.16M
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.90M
-163.07%-6.75M
-45.97%-4.88M
56.13%-3.40M
47.78%-3.04M
46.57%-2.57M
26.99%-3.34M
-51.98%-7.75M
83.28%-5.81M
Current assets
38.07%65.11M
31.37%80.59M
440.03%95.41M
318.56%107.62M
49.70%47.16M
60.06%61.35M
-62.49%17.67M
-16.38%25.71M
-13.15%31.50M
-7.67%38.33M
5.62%47.10M
-20.85%30.75M
-10.24%36.27M
-2.37%41.51M
-4.21%44.59M
-25.12%38.85M
-27.67%40.41M
-29.01%42.52M
115.37%46.56M
84.34%51.88M
Total current liabilities
161.81%23.65M
128.51%20.75M
51.42%12.99M
0.58%9.17M
171.07%9.03M
147.71%9.08M
14.84%8.58M
44.71%9.12M
-11.38%3.33M
15.32%3.67M
225.82%7.47M
316.39%6.30M
199.36%3.76M
80.83%3.18M
-38.69%2.29M
-49.19%1.51M
-47.00%1.26M
-22.18%1.76M
55.12%3.74M
-13.25%2.98M
Total assets
41.64%67.22M
34.47%82.78M
441.01%97.09M
313.31%107.78M
48.23%47.46M
57.93%61.56M
-62.52%17.95M
-16.37%26.08M
-12.78%32.02M
-7.18%38.98M
6.10%47.88M
-21.49%31.18M
-11.13%36.71M
-3.02%42.00M
-4.77%45.13M
-24.90%39.72M
-27.62%41.30M
-29.28%43.31M
108.49%47.39M
86.81%52.89M
Total liabilities
178.16%25.12M
139.93%21.79M
51.42%12.99M
0.58%9.17M
171.07%9.03M
147.71%9.08M
14.84%8.58M
44.71%9.12M
-11.38%3.33M
15.32%3.67M
225.82%7.47M
316.39%6.30M
199.36%3.76M
80.83%3.18M
-38.69%2.29M
-49.19%1.51M
-47.00%1.26M
-22.18%1.76M
55.12%3.74M
-13.25%2.98M
Total equity
9.56%42.10M
16.22%60.99M
797.90%84.10M
481.41%98.61M
33.96%38.43M
48.61%52.48M
-76.82%9.37M
-31.84%16.96M
-12.94%28.68M
-9.03%35.31M
-5.67%40.41M
-34.87%24.88M
-17.73%32.95M
-6.57%38.82M
-1.87%42.84M
-23.45%38.21M
-26.78%40.05M
-29.56%41.55M
114.82%43.65M
100.62%49.91M
Net operating income
-81.63%-18.81M
-64.51%-16.47M
-72.14%-14.00M
-69.49%-10.06M
-55.32%-10.36M
-11.60%-10.01M
10.21%-8.13M
-8.42%-5.94M
-28.11%-6.67M
-210.02%-8.97M
-366.91%-9.06M
-297.60%-5.47M
-163.49%-5.20M
19.24%-2.89M
62.16%-1.94M
65.03%-1.38M
50.99%-1.98M
5.81%-3.58M
33.75%-5.13M
-2194.68%-3.94M
Net investment
-100.00%0.00
100.00%0.00
---55.00K
--0.00
604916.67%36.29M
-224818.75%-35.99M
-100.00%0.00
100.00%0.00
---6.00K
---16.00K
--10.03M
---9.96M
----
----
----
----
----
--0.00
100.00%0.00
100.00%0.00
Net financing
103.19%74.00K
-99.98%9.00K
66350.00%1.32M
703590.00%70.35M
-28925.00%-2.32M
69269.33%51.88M
-100.01%-2.00K
58.33%-10.00K
-233.33%-8.00K
-36.36%-75.00K
233.02%24.78M
78.18%-24.00K
117.65%6.00K
-41.03%-55.00K
248100.00%7.44M
-279.31%-110.00K
-225.93%-34.00K
-100.09%-39.00K
-101.81%-3.00K
-100.12%-29.00K

FAQs

What are the current assets of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its current assets were 80.59M, with a year-on-year change of 31.37.

What are the total assets of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its total assets of Forte Biosciences Inc were 82.78M, with a year-on-year change of 34.47.

What are the total liabilities of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its total liabilities of Forte Biosciences Inc were 21.79M, with a year-on-year change of 139.93.

What is the total equity of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its total equity of Forte Biosciences Inc was 60.99M, with a year-on-year change of 16.22.

What is the net operating income of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its net operating income of Forte Biosciences Inc was -70.66M, with a year-on-year change of -93.04.

What is the net investment of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its net investment of Forte Biosciences Inc was 36.23M, with a year-on-year change of 200.67.

What is the net financing of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its net financing of Forte Biosciences Inc was 69.36M, with a year-on-year change of 33.75.

What is the Earnings Per Share (EPS) of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.71, with a year-on-year change of 61.29.

What is the net income of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its net income was -69.38M, with a year-on-year change of -95.54.

What is the Return on Equity (ROE) of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -122.28, with a year-on-year change of -51.29.

What is the Return on Assets (ROA) of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -96.13, with a year-on-year change of -36.21.

What is the operating profit of Forte Biosciences Inc?

According to Forte Biosciences Inc's FY2025 earnings report, its operating profit was -70.66M, with a year-on-year change of -93.04.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.